Vasculitis Pregnancy Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-30

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess

1. each woman's vasculitis severity and pregnancy-related experiences, and
2. pregnancy outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reproductive Health in Men and Women With Vasculitis

NCT02176070

Giant Cell Arteritis Takayasu's Arteritis Polyarteritis Nodosa +8 more

COMPLETED

Journey of Patients With Vasculitis From First Symptom to Diagnosis

NCT03410290

Vasculitis Systemic Vasculitis Behcet's Disease +13 more

COMPLETED

Impact of Vasculitis on Employment and Income

NCT02476292

Vasculitis Systemic Vasculitis Behcet's Disease +10 more

COMPLETED

VCRC Patient Contact Registry Patient-Reported Data Validation Study

NCT02190942

Behcet's Disease Churg-Strauss Syndrome Giant Cell Arteritis +4 more

COMPLETED

One-Time DNA Study for Vasculitis

NCT01241305

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) Giant Cell Arteritis Granulomatosis With Polyangiitis (Wegener's) +3 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will consist of several on-line surveys to assess each woman's vasculitis severity, pregnancy-related experiences, and pregnancy outcomes. Participants will be asked to complete questionnaires at study entry, during the second trimester, during the third trimester, and postpartum. Investigators estimate that it will take approximately 20 minutes to complete each survey. The survey is available in Spanish, Portuguese, Italian, and Turkish.

All women enrolled in the Vasculitis Patient-Powered Research Network (VPPRN) (with specified disease, sex, and age inclusion criteria described below) will be invited via email to participate in this on-line study. The survey data will be stored by the Data Management and Coordinating Center (DMCC) at the University of South Florida. Upon conclusion of the study period, the data will be sent to the Study Chairs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vasculitis Behcet's Disease CNS Vasculitis Cryoglobulinemic Vasculitis Eosinophilic Granulomatosis With Polyangiitis (EGPA) Churg-Strauss Syndrome (CSS) Granulomatosis With Polyangiitis (GPA) Wegener's Granulomatosis IgA Vasculitis Henoch-Schoenlein Purpura (HSP) Microscopic Polyangiitis (MPA) Polyarteritis Nodosa (PAN) Takayasu Arteritis (TAK) Urticarial Vasculitis Systemic Vasculitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Woman, 18 years of age or older, currently pregnant, and have a diagnosis of vasculitis.

Online questionnaires

Intervention Type OTHER

Women will be asked to complete questionnaires during their pregnancy and a postpartum questionnaire.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online questionnaires

Women will be asked to complete questionnaires during their pregnancy and a postpartum questionnaire.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women 18 years of age or older with one of the following diseases may take part in the study:

* Behçet's disease;
* Central nervous system (CNS) vasculitis;
* Cryoglobulinemic vasculitis (Cryoglobulinemia);
* Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
* Giant Cell (Temporal) Arteritis (GCA);
* Granulomatosis with polyangiitis (also called Wegener's);
* IgA vasculitis (Henoch-Schoenlein purpura);
* Microscopic polyangiitis (MPA);
* Polyarteritis nodosa (PAN);
* Takayasu's arteritis (TAK);
* Urticarial vasculitis;
* Other/Suspected Diagnosis.
2. Women must be pregnant (self-report) at the time of enrollment into the registry.